Incidence rates are adjusted to account for differences in age structure across countries.
5, version 2.0 (Lyon, France: IARC, 2004).
Bethesda, Md: National cancer institute, 1998.
IARC working group on evaluation of cervical cancer screening programs. Br Med J (Clin Res Ed) 1986;293:659
Estimating the efficacy of screening by auditing smear, histories of women with and without cervical cancer. The national coordinating network for cervical screening working Group. Br J Cancer 1996;73:1001
Effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol 1995;85:1017-21.
University of Zimbabwe/ JHPIEGO cervical cancer project. Lancet 1999;353:896
Achievable laboratory standards; a review of cytology of 99 women with cervical cancer. Cytopathology 1998;9:171
Cytological detection of cervical cancer in black Africa: What are the perspectives? Bull cancer 1996;83:407
Awareness campaign; Experience in Mexico. Vaccine 2000;(suppl-1):590-92.